Carl H. June, MD
Carl H. June, MD, was awarded the inaugural Maria I. New International Prize for Biomedical Research by Mount Sinai at the Icahn School of Medicine. The award recognizes medical pioneers in honor of Maria I. New, MD, who dedicated more than 60 years to breakthrough research.
The Maria I. New International Prize for Biomedical Research will be awarded annually to recognize and honor lifetime achievements by biomedical researchers. Recipients are selected by an international jury of leading individuals in the science community and are awarded $20,000.
Dr. June is an inventor of chimeric antigen receptor (CAR) T-cell therapy. In addition to the countless clinical trials evaluating CAR T therapies in numerous cancers, six CAR T-cell therapies have received U.S. Food and Drug Administration approval to date. He has also done work in HIV cellular therapy.
Dr. June is the Richard W. Vague Professor in immunotherapy in the Department of Pathology and Laboratory Medicine, director of the Center for Cellular Immunotherapies, and director of the Parker Institute for Cancer Immunotherapy, all at the Perelman School of Medicine at the University of Pennsylvania.
“As its inaugural recipient, Carl exemplifies a distinguished scientist whose achievements have led to a transformative treatment paradigm for otherwise debilitating cancers, and by doing so, has upheld the legacy of Dr. Maria New and her lifetime contributions,” said Mone Zaidi, MD, PhD, director of Mount Sinai’s Center for Translational Medicine and Pharmacology and professor of clinical medicine at the Icahn School of Medicine.
Source: Mount Sinai, November 11, 2022; Mount Sinai, September 29, 2022.
